Medication

FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 8:48 am
WASHINGTON (AP) — The Latest on President Donald Trump's plan to lower prescription drug prices (all times local): 11:40 a.m. The drug industry lobby says the Trump administration's plan to let Americans import cheaper prescription drugs from Canada is "far too dangerous." Pharmaceutical Research...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 1:05 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar said Tuesday. Azar made his comments during an interview with CNBC, saying he had just gotten off the phone...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 12:59 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
Cancer patient Kim Lauerman poses for a portrait in her home Wednesday, June 26, 2019, in Alpharetta, Ga. After Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Doctors say they worry about the growing influence insurers have over patient care. They say treatment delays and the problems they create are becoming common because routine things like imaging exams or prescriptions now require insurer approval first. (AP Photo/John Bazemore)
July 29, 2019 - 11:01 am
After Kim Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Anthem Blue Cross told Lauerman the drug wasn't necessary. She eventually got it after an infection landed her in the hospital,...
Read More
FILE - In this April 26, 2019, file photo, RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc., the biggest U.S.-based drugmaker, reported a 30% jump in second-quarter profits on Monday, July 29. (AP Photo/Wilfredo Lee, File)
July 29, 2019 - 10:39 am
Pfizer is spinning off a big chunk of the company, culminating a rare tear of major deals aimed at reshaping the drugmaker into a slimmed-down version with faster, more-sustainable growth. The biggest U.S.-based drugmaker announced the latest move on Monday — combining its Upjohn business, which...
Read More
July 25, 2019 - 12:10 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
House Speaker Nancy Pelosi of Calif. and House Democrats arrive for a news conference on the first 200 days of the 116th Congress at the House east front steps on Capitol Hill, in Washington, Thursday, July 25, 2019. (AP Photo/Andrew Harnik)
July 25, 2019 - 9:30 am
WASHINGTON (AP) — Congressional Democrats on Thursday pivoted away from questions of impeachment by saying they are going to "own" the upcoming August recess on issues like health care and prescription drug costs. Not emphasized was the testimony a day earlier by former special counsel Robert...
Read More
FILE - This April 30, 2007, file photo, shows the headquarters of Cardinal Health in Dublin, Ohio. An executive at Cardinal Health, one of the nation’s largest drug distribution companies, said in a legal proceeding that the business has no obligation to the public when it comes to shipping prescription opioid painkillers. That’s one of the disclosures in thousands of pages of court documents made public July 23, 2019, in lawsuits over the opioid crisis. (AP Photo/Kiichiro Sato, File)
July 24, 2019 - 11:56 am
WASHINGTON (AP) — In 2012, as the death toll from the nation's opioid crisis mounted, drug companies shipped out enough of the powerful and addictive painkillers for every man, woman and child in the U.S. to have nearly a 20-day supply. In some counties, mostly in Appalachia, it was well over 100...
Read More
July 23, 2019 - 7:27 am
WASHINGTON (AP) — Two senior senators — one Republican, one Democrat — are unveiling compromise legislation to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs. Staffers for Iowa Republican Charles Grassley and Oregon...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 7:37 am
WASHINGTON (AP) — Nearly a decade ago, the maker of OxyContin responded to a growing wave of opioid abuse by making the painkiller harder to snort and inject. But has that reformulation translated into fewer drug overdoses and deaths? It's a question that experts like Dr. Raeford Brown of the...
Read More

Pages